Microbial influences in inflammatory bowel diseases

被引:1516
|
作者
Sartor, R. Balfour [1 ,2 ]
机构
[1] Univ N Carolina, Dept Med, Chapel Hill, NC USA
[2] Univ N Carolina, Dept Med, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA
关键词
D O I
10.1053/j.gastro.2007.11.059
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The predominantly anaerobic microbiota of the distal ileum and colon contain an extraordinarily complex variety of metabolically active bacteria and fungi that intimately interact with the host's epithelial cells and mucosal immune system. Crohn's disease, ulcerative colitis, and pouchitis are the result of continuous microbial antigenic stimulation of pathogenic immune responses as a consequence of host genetic defects in mucosal barrier function, innate bacterial killing, or immunoregulation. Altered microbial composition and function in inflammatory bowel diseases result in increased immune stimulation, epithelial dysfunction, or enhanced mucosal permeability. Although traditional pathogens probably are not responsible for these disorders, increased virulence of commensal bacterial species, particularly Escherichia coli, enhance their mucosal attachment, invasion, and intracellular persistence, thereby stimulating pathogenic immune responses. Host genetic polymorphisms most likely interact with functional bacterial changes to stimulate aggressive immune responses that lead to chronic tissue injury. Identification of these host and microbial alterations in individual patients should lead to selective targeted interventions that correct underlying abnormalities and induce sustained and predictable therapeutic responses.
引用
收藏
页码:577 / 594
页数:18
相关论文
共 50 条
  • [41] Immunotherapy in Inflammatory Bowel Diseases
    Neurath, M.
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2012, 62 : S13 - S13
  • [42] Chronic inflammatory Bowel Diseases
    Schoepfer, Alain
    THERAPEUTISCHE UMSCHAU, 2018, 75 (05) : 253 - 253
  • [43] Chemokines in Inflammatory Bowel Diseases
    Atreya, Raja
    Neurath, M. F.
    DIGESTIVE DISEASES, 2010, 28 (03) : 386 - 394
  • [44] Chronic inflammatory bowel diseases
    Moessner, J.
    Siegmund, B.
    INTERNIST, 2014, 55 (08): : 881 - 882
  • [45] Chronic Inflammatory Bowel Diseases
    Stange, Eduard F.
    Kruis, Wolfgang
    Rogler, Gerhard
    Schilling, Martin
    Stallmach, Andreas
    VISZERALMEDIZIN, 2009, 25 (04): : 230 - 233
  • [46] Etiopathogenesis of inflammatory bowel diseases
    Silvio Danese
    Claudio Fiocchi
    World Journal of Gastroenterology, 2006, (30) : 4807 - 4812
  • [47] Epidemiology and inflammatory bowel diseases
    El-Tawil, Ahmed Mahmoud
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (10) : 1505 - 1507
  • [48] Pancreas and Inflammatory Bowel Diseases
    Delakidis, Stergios
    ANNALS OF GASTROENTEROLOGY, 2006, 19 (02): : 174 - 180
  • [49] The pancreas and inflammatory bowel diseases
    Klaus R. Herrlinger
    Eduard F. Stange
    International Journal of Pancreatology, 2000, 27 : 171 - 179
  • [50] Lmmunopathogenesis of inflammatory bowel diseases
    Neurath, MF
    DISEASE PROGRESSION AND CARCINOGENESIS IN THE GASTROINTESTINAL TRACT, 2003, 132 : 109 - 116